Drug
Ibezapolstat
Ibezapolstat: highest development phase Phase 2, developed by Acurx Pharmaceuticals Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Acurx Pharmaceuticals Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ibezapolstat NCT07513285 | Phase 2 | Clostridium Difficile Infection Recurrence |
Latest
No recent events.
Follow Ibezapolstat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.